Please Wait.....
Report
Middle East and Africa Cold Sore Treatment (for HSV 1 Virus) Market
Market Report I 2024-05-01 I 218 Pages I Data Bridge Market Research
Middle East and Africa cold sore treatment (for HSV 1 virus) market is expected to reach USD 72.64 million by 2031, from USD 49.51 million in 2023 growing at the CAGR of 5.3% in the forecast period of 2024 to 2031.
Market Segmentation
Middle East and Africa Cold Sore Treatment (for HSV 1 Virus) Market, By Treatment Type (Medications, Applied Products, Cold Sore Patches, and Others(Non Medicated Products)), Route Of Administration (Oral, Topical, and Others), Mode Of Purchase (Over The Counter and Prescription Drug), Strain Type (Herpes Simplex Type 1 Virus and Herpes Simplex Type 2 Virus), Drug Type (Generic and Branded), Population Type (Adults, Pediatrics, and Geriatrics), Gender (Female and Male), End User (Home Healthcare, Hospitals, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), By Country (South Africa, Egypt, Saudi Arabia, U.A.E., and rest of Middle East and Africa) - Industry Trends and Forecast to 2031
Overview of Middle East and Africa Cold Sore Treatment (for HSV 1 Virus) Market Dynamics
Drivers
- Growing prevalence of cold sore infection
- Growing awareness about cold sore symptoms and treatment options
- Impact of generic drugs on the global cold sore treatment (for HSV 1 virus) market
Restraints
- Development of drug-resistant strains of HSV-1 and H11 viruses
- Lack of curative treatment for infection
Opportunities
- Rising advancements in treatments for cold sore infections
- Increasing adoption of telemedicine and digital health solutions
Challenges
- Increasing complexity of vaccine development
- Side effects associated with medications in treating cold sore
Market Players
The key market players for Middle East and Africa cold sore treatment (for HSV 1 virus) market are listed below:
- Fresenius SE & Co. KGaA
- Zydus Pharmaceuticals, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Quantum Health
- GSK plc.
- Haleon Group of Companies
- Church & Dwight Co., Inc.
- Hikma Pharmaceuticals PLC
- Viatris Inc.
- Carma Labs Inc.
- URGO MEDICAL
- Apotex Inc.
- Amneal Pharmaceuticals LLC
- Blistex Inc.
- FOCUS CONSUMER HEALTHCARE
- Hetero Healthcare Limited
- Amparo medical Technologies
- Devirex AG
1 INTRODUCTION 48
1.1 OBJECTIVES OF THE STUDY 48
1.2 MARKET DEFINITION 48
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET 48
1.4 CURRENCY AND PRICING 50
1.5 LIMITATIONS 50
1.6 MARKETS COVERED 50
2 MARKET SEGMENTATION 54
2.1 MARKETS COVERED 54
2.2 GEOGRAPHICAL SCOPE 55
2.3 YEARS CONSIDERED FOR THE STUDY 56
2.4 DBMR TRIPOD DATA VALIDATION MODEL 57
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 60
2.6 MULTIVARIATE MODELLING 61
2.7 MARKET APPLICATION COVERAGE GRID 62
2.8 PRODUCT LIFELINE CURVE 63
2.9 DBMR MARKET POSITION GRID 64
2.10 VENDOR SHARE ANALYSIS 65
2.11 SECONDARY SOURCES 66
2.12 ASSUMPTIONS 66
3 EXECUTIVE SUMMARY 67
4 PREMIUM INSIGHTS 70
4.1 PESTEL ANALYSIS 71
4.2 PORTER'S FIVE FORCES 72
5 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET: REGULATIONS 73
5.1 REGULATION IN U.S.: 73
5.2 REGULATION IN CANADA: 74
5.3 REGULATION IN SPAIN: 74
5.4 REGULATION IN U.K.: 75
5.5 REGULATION IN INDIA 76
?
6 MARKET OVERVIEW 78
6.1 DRIVERS 80
6.1.1 GROWING PREVALENCE OF COLD SORE INFECTION 80
6.1.2 GROWING AWARENESS ABOUT COLD SORE SYMPTOMS AND TREATMENT OPTIONS 80
6.1.3 IMPACT OF GENERIC DRUGS ON THE MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET 81
6.2 RESTRAINTS 82
6.2.1 DEVELOPMENT OF DRUG-RESISTANT STRAINS OF HSV-1 AND H11 VIRUSES 82
6.2.2 LACK OF CURATIVE TREATMENT FOR INFECTION 83
6.3 OPPORTUNITIES 84
6.3.1 RISING ADVANCEMENTS IN TREATMENTS FOR COLD SORE INFECTIONS 84
6.3.2 INCREASING ADOPTION OF TELEMEDICINE AND DIGITAL HEALTH SOLUTIONS 85
6.4 CHALLENGES 86
6.4.1 INCREASING COMPLEXITY OF VACCINE DEVELOPMENT 86
6.4.2 SIDE EFFECTS ASSOCIATED WITH MEDICATIONS IN TREATING COLD SORE 87
7 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY TREATMENT TYPE 88
7.1 OVERVIEW 89
7.2 MEDICATIONS 92
7.2.1 ANTIVIRAL AGENTS 92
7.2.2 ANALGESIC AGENTS 93
7.2.3 OTHERS 93
7.3 APPLIED PRODUCTS 93
7.3.1 BRANDED 94
7.3.2 GENERICS 94
7.4 COLD SORE PATCHES 95
7.4.1 SEMI OCCLUSIVE HYDROCOLLOID PATCH 95
7.4.2 FILM FORMING PATCH 95
7.5 OTHERS (NON MEDICATED PRODUCTS) 96
8 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY ROUTE OF ADMINISTRATION 97
8.1 OVERVIEW 98
8.2 ORAL 101
8.2.1 TABLETS 101
8.2.2 CAPSULES 101
8.2.3 OTHERS 101
?
8.3 TOPICAL 102
8.3.1 CREAM 102
8.3.2 LIP BALM 102
8.3.3 OTHERS 102
8.4 OTHERS 103
9 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY MODE OF PURCHASE 104
9.1 OVERVIEW 105
9.2 OVER THE COUNTER 108
9.3 PRESCRIPTION DRUG 108
10 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV1 VIRUS) MARKET, BY STRAIN TYPE 109
10.1 OVERVIEW 110
10.2 HERPES SIMPLEX TYPE 1 VIRUS 113
10.3 HERPES SIMPLEX TYPE 2 VIRUS 113
11 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV1 VIRUS) MARKET, BY DRUG TYPE 114
11.1 OVERVIEW 115
11.2 GENERIC 118
11.3 BRANDED 118
12 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV1 VIRUS) MARKET, BY POPULATION TYPE 120
12.1 OVERVIEW 121
12.2 ADULTS 124
12.3 PEDIATRICS 124
12.4 GERIATRICS 125
13 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV1 VIRUS) MARKET, BY GENDER 126
13.1 OVERVIEW 127
13.2 FEMALE 130
13.3 MALE 130
?
14 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV1 VIRUS) MARKET, BY END USER 131
14.1 OVERVIEW 132
14.2 HOME HEALTHCARE 135
14.3 HOSPITALS 135
14.4 SPECIALTY CLINICS 136
14.5 OTHERS 136
15 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV1 VIRUS) MARKET, BY DISTRIBUTION CHANNEL 137
15.1 OVERVIEW 138
15.2 DIRECT TENDERS 141
15.3 RETAIL SALES 141
16 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET, BY REGION 143
16.1 MIDDLE EAST AND AFRICA 146
16.1.1 SOUTH AFRICA 153
16.1.2 EGYPT 160
16.1.3 SAUDI ARABIA 166
16.1.4 U.A.E. 173
17 MIDDLE EAST AND AFRICA COLD SORE TREATMENT (FOR HSV 1 VIRUS) MARKET: COMPANY LANDSCAPE 180
17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
18 SWOT ANALYSIS 181
19 COMPANY PROFILE 182
19.1 FRESENIUS SE & CO. KGAA 182
19.1.1 COMPANY SNAPSHOT 182
19.1.2 REVENUE ANALYSIS 182
19.1.3 COMPANY SHARE ANALYSIS 183
19.1.4 PRODUCT PORTFOLIO 183
19.1.5 RECENT DEVELOPMENT 183
19.2 ZYDUS PHARMACEUTICALS INC. 184
19.2.1 COMPANY SNAPSHOT 184
19.2.2 COMPANY SHARE ANALYSIS 184
19.2.3 PRODUCT PORTFOLIO 185
19.2.4 RECENT DEVELOPMENT 185
19.3 TEVA PHARMACEUTICAL INDUSTRIES LTD. 186
19.3.1 COMPANY SNAPSHOT 186
19.3.2 REVENUE ANALYSIS 186
19.3.3 COMPANY SHARE ANALYSIS 187
19.3.4 PRODUCT PORTFOLIO 187
19.3.5 RECENT DEVELOPMENT 188
19.4 NOVARTIS AG 189
19.4.1 COMPANY SNAPSHOT 189
19.4.2 REVENUE ANALYSIS 189
19.4.3 COMPANY SHARE ANALYSIS 190
19.4.4 PRODUCT PORTFOLIO 190
19.4.5 RECENT DEVELOPMENT 190
19.5 SUN PHARMACEUTICALS INDUSTRIES LIMITED 191
19.5.1 COMPANY SNAPSHOT 191
19.5.2 REVENUE ANALYSIS 191
19.5.3 COMPANY SHARE ANALYSIS 192
19.5.4 PRODUCT PORTFOLIO 192
19.5.5 RECENT DEVELOPMENT 192
19.6 AMNEAL PHARMACEUTICALS LLC 193
19.6.1 COMPANY SNAPSHOT 193
19.6.2 REVENUE ANALYSIS 193
19.6.3 PRODUCT PORTFOLIO 194
19.6.4 RECENT DEVELOPMENT 194
19.7 AMPARO MEDICAL TECHNOLOGIES 195
19.7.1 COMPANY SNAPSHOT 195
19.7.2 PRODUCT PORTFOLIO 195
19.7.3 RECENT DEVELOPMENT 195
19.8 APOTEX INC. 196
19.8.1 COMPANY SNAPSHOT 196
19.8.2 PRODUCT PORTFOLIO 196
19.8.3 RECENT DEVELOPMENT 196
19.9 BLISTEX INC. 197
19.9.1 COMPANY SNAPSHOT 197
19.9.2 PRODUCT PORTFOLIO 197
19.9.3 RECENT DEVELOPMENT 197
19.10 CARMA LABS INC. 198
19.10.1 COMPANY SNAPSHOT 198
19.10.2 PRODUCT PORTFOLIO 198
19.10.3 RECENT DEVELOPMENT 198
?
19.11 CHURCH & DWIGHT CO., INC. 199
19.11.1 COMPANY SNAPSHOT 199
19.11.2 REVENUE ANALYSIS 199
19.11.3 PRODUCT PORTFOLIO 200
19.11.4 RECENT DEVELOPMENT 200
19.12 DEVIREX AG 201
19.12.1 COMPANY SNAPSHOT 201
19.12.2 PRODUCT PORTFOLIO 201
19.12.3 RECENT DEVELOPMENT 201
19.13 FOCUS CONSUMER HEALTHCARE 202
19.13.1 COMPANY SNAPSHOT 202
19.13.2 PRODUCT PORTFOLIO 202
19.13.3 RECENT DEVELOPMENT 202
19.14 GSK PLC. 203
19.14.1 COMPANY SNAPSHOT 203
19.14.2 REVENUE ANALYSIS 203
19.14.3 PRODUCT PORTFOLIO 204
19.14.4 RECENT DEVELOPMENT 204
19.15 HALEON GROUP OF COMPANIES 205
19.15.1 COMPANY SNAPSHOT 205
19.15.2 REVENUE ANALYSIS 205
19.15.3 PRODUCT PORTFOLIO 206
19.15.4 RECENT DEVELOPMENT 206
19.16 HETERO HEALTH CARE LIMITED 207
19.16.1 COMPANY SNAPSHOT 207
19.16.2 PRODUCT PORTFOLIO 207
19.16.3 RECENT DEVELOPMENT 207
19.17 HIKMA PHARMACEUTICALS PLC 208
19.17.1 COMPANY SNAPSHOT 208
19.17.2 REVENUE ANALYSIS 208
19.17.3 PRODUCT PORTFOLIO 209
19.17.4 RECENT DEVELOPMENT 209
19.18 QUANTUM HEALTH 210
19.18.1 COMPANY SNAPSHOT 210
19.18.2 PRODUCT PORTFOLIO 210
19.18.3 RECENT DEVELOPMENT 211
19.19 URGO MEDICAL 212
19.19.1 COMPANY SNAPSHOT 212
19.19.2 PRODUCT PORTFOLIO 212
19.19.3 RECENT DEVELOPMENT 212
19.20 VIATRIS INC. 213
19.20.1 COMPANY SNAPSHOT 213
19.20.2 REVENUE ANALYSIS 213
19.20.3 PRODUCT PORTFOLIO 214
19.20.4 RECENT DEVELOPMENT 214
20 QUESTIONNAIRE 215
21 RELATED REPORTS 218
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security